Vitamin D levels are low in adult patients with sickle cell disease in Jamaica and West Africa
暂无分享,去创建一个
A. Luke | R. Cooper | B. Tayo | C. Mckenzie | J. Layden | B. Salako | J. Plange-Rhule | R. Durazo-Arvizu | M. Reid | I. Osunkwo | T. Akingbola | C. McKenzie
[1] Christine L. Taylor,et al. Dietary Reference Intakes for Calcium and Vitamin D , 2016, Pediatric Clinical Practice Guidelines & Policies.
[2] R. Cooper,et al. Comparison of Patients from Nigeria and the USA Highlights Modifiable Risk Factors for Sickle Cell Anemia Complications , 2014, Hemoglobin.
[3] C. Palacios,et al. Is vitamin D deficiency a major global public health problem? , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[4] A. Luke,et al. 25‐hydroxyvitamin D levels in African American and Nigerian women , 2013, American journal of human biology : the official journal of the Human Biology Council.
[5] I. Kema,et al. Vitamin D status indicators in indigenous populations in East Africa , 2013, European Journal of Nutrition.
[6] M. Gershwin,et al. The Implication of Vitamin D and Autoimmunity: a Comprehensive Review , 2013, Clinical Reviews in Allergy & Immunology.
[7] S. Ofori-Acquah,et al. High dose vitamin D therapy for chronic pain in children and adolescents with sickle cell disease: results of a randomized double blind pilot study , 2012, British journal of haematology.
[8] C. Cooper,et al. A global representation of vitamin D status in healthy populations , 2012, Archives of Osteoporosis.
[9] Frederick G. Strathmann,et al. 3-epi-25 hydroxyvitamin D concentrations are not correlated with age in a cohort of infants and adults. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[10] U. Ekelund,et al. Protocol for the modeling the epidemiologic transition study: a longitudinal observational study of energy balance and change in body weight, diabetes and cardiovascular disease risk , 2011, BMC public health.
[11] I. Osunkwo. Complete resolution of sickle cell chronic pain with high dose vitamin D therapy: a case report and review of the literature. , 2011, Journal of pediatric hematology/oncology.
[12] P. Lips,et al. Worldwide status of vitamin D nutrition , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[13] A. Hoofnagle,et al. A rubber transfer gasket to improve the throughput of liquid-liquid extraction in 96-well plates: application to vitamin D testing. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[14] N. Jablonski,et al. Human skin pigmentation as an adaptation to UV radiation , 2010, Proceedings of the National Academy of Sciences.
[15] William Wheeler,et al. Genome-wide association study of circulating vitamin D levels , 2010, Human molecular genetics.
[16] I. Chen,et al. Prevalence of vitamin D deficiency in adults with sickle cell disease. , 2010, Journal of the National Medical Association.
[17] F. Cantatore,et al. Vitamin D and the Immune System , 2010, The Journal of Rheumatology.
[18] M. Lehtinen,et al. The Effects of Storage Time and Sampling Season on the Stability of Serum 25-Hydroxy Vitamin D and Androstenedione , 2009, Nutrition and cancer.
[19] J. Souberbielle,et al. Osteopenia and vitamin D deficiency in children with sickle cell disease , 2009, European journal of haematology.
[20] T. Pieber,et al. Vitamin D status and arterial hypertension: a systematic review , 2009, Nature Reviews Cardiology.
[21] N. Jablonski,et al. Vitamin D and the evolution of human depigmentation. , 2009, American journal of physical anthropology.
[22] D. Cole,et al. Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. , 2009, Clinical biochemistry.
[23] B. Zemel,et al. High risk of vitamin D deficiency in children with sickle cell disease. , 2008, Journal of the American Dietetic Association.
[24] J. Norris,et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. , 2008, The Journal of clinical endocrinology and metabolism.
[25] J. Aloia. African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. , 2008, The American journal of clinical nutrition.
[26] M. Holick,et al. Sickle cell bone disease: Response to vitamin D and calcium , 2008, American journal of hematology.
[27] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.
[28] Michael J. Pencina,et al. Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.
[29] K. Badenhoop,et al. CYP2R1 (vitamin D 25‐hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans , 2007, Diabetes/metabolism research and reviews.
[30] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[31] M. Holick. Vitamin D deficiency. , 2007, The New England journal of medicine.
[32] G. Velho,et al. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. , 2005, Diabetes & metabolism.
[33] G. Chaplin. Geographic distribution of environmental factors influencing human skin coloration. , 2004, American journal of physical anthropology.
[34] B. Zemel,et al. Low vitamin D status in children with sickle cell disease. , 2004, The Journal of pediatrics.
[35] S. Nicolai,et al. A review of evidence , 2015 .
[36] E. Michos. Vitamin D deficiency and the risk of incident Type 2 diabetes. , 2009, Future cardiology.
[37] D. Black,et al. Serum 25-hydroxyvitamin D is unaffected by multiple freeze-thaw cycles. , 2005, Clinical chemistry.